---
title: ExperTrials vs Indero
slug_a: expertrials
slug_b: inderocro
site: cro
review_signal_gate: closed
canonical_path: /compare/expertrials/inderocro
---

# ExperTrials vs Indero

Side-by-side profile data from each company listing on this directory.

## ExperTrials

- Profile: [/companies/expertrials](/companies/expertrials)

ExperTrials — European-based full-service CRO supporting biotech and medtech companies from Phase I through Phase IV and market access, with 80+ senior clinical research associates across Europe and the USA.

Services: 12. Modalities: 0. Indications: 6. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (12).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- EU EMA Regulatory Strategy
- Device & Combination Product Services

### Modalities

- Data not yet provided.

### Indications

- Oncology
- Neurology
- Cardiovascular
- Infectious Disease
- Rare Disease
- Gastroenterology

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## Indero

- Profile: [/companies/inderocro](/companies/inderocro)

Indero — Indero is a dual-focus CRO specializing in dermatology and rheumatology clinical trials, offering end-to-end services from early to late phase with global capabilities across North America, Europe, Latin America, and Asia-Pacific.

Services: 11. Modalities: 0. Indications: 2. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- Translational Research

### Modalities

- Data not yet provided.

### Indications

- Immunology
- Dermatology

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)